Biomarkers Predicting Atrial High Rate Episodes in Cardiac Implantable Electronic Device Recipients

NCT ID: NCT05475860

Last Updated: 2022-07-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-07-24

Study Completion Date

2024-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is sought to investigate any predictors including biomarkers for atrial high rate episodes (AHRE) occurrence in patients without prior history of atrial tachyarrhythmias receiving cardiac implantable electronic device (CIED).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Atrial high rate episodes (AHRE) are noticed up to 70% in patients receiving cardiac implantable electronic device (CIED) even in the absence of prior history of atrial tachyarrhythmias. AHRE is clinically important because it is considered to be associated with clinical atrial fibrillation, stroke, mortality, and heart failure hospitalization. Therefore, predictors of AHRE might be useful for early detection of AHRE susceptable CIED recipients. Biomarkers as well as clinical characteristics will be analyzed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atrial High Rate Episode Cardiac Implantable Electronic Device

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients receiving cardiac implantable electronic device

Patients receiving cardiac implantable electronic device for any clinical indication

implantable cardiac electronic device recipients

Intervention Type DEVICE

implantable cardiac electronic device recipients for any clinical indication

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

implantable cardiac electronic device recipients

implantable cardiac electronic device recipients for any clinical indication

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

pacemaker implantable cardioverter-defibrillator cardiac resynchronization therapy

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients receiving cardiac implantable electronic device

Exclusion Criteria

* patients who disagree for blood sampling to analyze not commonly used clinical biomarkers
* patients not followed-up at least 12 months after implanting device
Minimum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pusan National University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jinhee Ahn, MD

Clinical associate professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jinhee Ahn, MD

Role: PRINCIPAL_INVESTIGATOR

Clinical associate professor

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Jinhee Ahn

Busan, , South Korea

Site Status

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jinhee Ahn, MD

Role: CONTACT

82-10-4840-5563

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

H-1803

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Specific Electrophenotypes in Atrial Fibrillation
NCT05366530 ACTIVE_NOT_RECRUITING